Commentary on “Use of Rheumatologic Testing in Patients Who Eventually Receive a Diagnosis of Rheumatoid Arthritis”
AbstractRheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disorder of unknown etiology, for which delay in diagnosis and treatment may cause irreversible structural joint damage in affected individuals. A large body of evidence supports that early diagnosis and aggressive treatment of RA have a fundamental role in the prevention of irreversible joint damage and consequent disability.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($15)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.